Article
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
2020-01-31
Abstract excerpt
Insulin-induced hypoglycemia is a major barrier to the treatment of type-1 diabetes (T1D). Accordingly, it is important that we understand the mechanisms regulating the circulating levels of glucagon – the body’s principal blood glucose-elevating hormone which is secreted from alpha-cells of the pancreatic islets. Varying glucose over the range of concentrations that occur physiologically between the fed and fuel-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f678373-8399-5b62-95a5-55532085bb45
- DOI
- 10.1101/2020.01.30.927426
